Anick Chalifour

986 total citations
11 papers, 780 citations indexed

About

Anick Chalifour is a scholar working on Immunology, Epidemiology and Virology. According to data from OpenAlex, Anick Chalifour has authored 11 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Epidemiology and 2 papers in Virology. Recurrent topics in Anick Chalifour's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (6 papers) and Herpesvirus Infections and Treatments (4 papers). Anick Chalifour is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (6 papers) and Herpesvirus Infections and Treatments (4 papers). Anick Chalifour collaborates with scholars based in Canada, Switzerland and France. Anick Chalifour's co-authors include Jean‐François Gauchat, Martine Malissard, Yves Delneste, Pascale Jeannin, Nathalie Thiéblemont, Aline Blaecke, Thien Ngoc Nguyen, Werner Held, Jonathan Back and Léonardo Scarpellino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Anick Chalifour

11 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anick Chalifour Canada 9 572 200 178 110 88 11 780
Kevin B. Gurney United States 11 460 0.8× 267 1.3× 129 0.7× 189 1.7× 138 1.6× 15 684
Michèle Février France 16 570 1.0× 354 1.8× 272 1.5× 185 1.7× 246 2.8× 32 965
Eva-Liz Johansson Sweden 8 461 0.8× 97 0.5× 243 1.4× 145 1.3× 124 1.4× 9 818
Teodor-Doru Brumeanu United States 11 573 1.0× 82 0.4× 105 0.6× 222 2.0× 84 1.0× 16 842
Madelene Lindqvist United States 14 857 1.5× 598 3.0× 286 1.6× 240 2.2× 193 2.2× 22 1.2k
Phil Felgner United States 9 350 0.6× 232 1.2× 311 1.7× 331 3.0× 161 1.8× 13 854
Lorenzo Diomede Italy 10 257 0.4× 334 1.7× 122 0.7× 125 1.1× 123 1.4× 12 503
Diane G. Carnathan United States 18 423 0.7× 379 1.9× 210 1.2× 177 1.6× 237 2.7× 33 817
Thandavarayan Nagashunmugam United States 14 199 0.3× 222 1.1× 313 1.8× 133 1.2× 114 1.3× 25 624
Danushka K. Wijesundara Australia 16 344 0.6× 120 0.6× 252 1.4× 195 1.8× 184 2.1× 39 741

Countries citing papers authored by Anick Chalifour

Since Specialization
Citations

This map shows the geographic impact of Anick Chalifour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anick Chalifour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anick Chalifour more than expected).

Fields of papers citing papers by Anick Chalifour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anick Chalifour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anick Chalifour. The network helps show where Anick Chalifour may publish in the future.

Co-authorship network of co-authors of Anick Chalifour

This figure shows the co-authorship network connecting the top 25 collaborators of Anick Chalifour. A scholar is included among the top collaborators of Anick Chalifour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anick Chalifour. Anick Chalifour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Leroux‐Roels, Geert, Cathy Maes, Frédéric Clément, et al.. (2013). Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes. PLoS ONE. 8(2). e55438–e55438. 59 indexed citations
2.
Bomsel, Morgane, Daniela Tudor, Anne-Sophie Drillet, et al.. (2011). Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges. Immunity. 34(2). 269–280. 226 indexed citations
3.
Chalifour, Anick, Léonardo Scarpellino, Jonathan Back, et al.. (2009). A Role for cis Interaction between the Inhibitory Ly49A Receptor and MHC Class I for Natural Killer Cell Education. Immunity. 30(3). 337–347. 99 indexed citations
4.
Back, Jonathan, Anick Chalifour, Léonardo Scarpellino, & Werner Held. (2007). Stable masking by H-2Ddcis ligand limits Ly49A relocalization to the site of NK cell/target cell contact. Proceedings of the National Academy of Sciences. 104(10). 3978–3983. 38 indexed citations
5.
Held, Werner, Anick Chalifour, & Jérôme D. Coudert. (2005). Regulation of natural killer cell function: a role for the NK cell’s own MHC class I molecules. Medical Microbiology and Immunology. 194(4). 169–174. 3 indexed citations
6.
Chalifour, Anick, Pascale Jeannin, Jean‐François Gauchat, et al.. (2004). Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers α-defensin production. Blood. 104(6). 1778–1783. 278 indexed citations
7.
8.
Chalifour, Anick, et al.. (2001). Cutting Edge: Ly49A Inhibits TCR/CD3-Induced Apoptosis and IL-2 Secretion. The Journal of Immunology. 167(1). 6–10. 29 indexed citations
9.
Depatie, Chantal, et al.. (1999). Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets. International Immunology. 11(9). 1541–1551. 21 indexed citations
10.
11.
Simard, Claire, Isabelle Langlois, Bernd Vogt, et al.. (1995). Sequence Analysis of the UL39, UL38, and UL37 Homologues of Bovine Herpesvirus 1 and Expression Studies of UL40 and UL39, the Subunits of Ribonucleotide Reductase. Virology. 212(2). 734–740. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin B. Gurney Breakdown of academic impact, for papers by Michèle Février Breakdown of academic impact, for papers by Eva-Liz Johansson Breakdown of academic impact, for papers by Teodor-Doru Brumeanu Breakdown of academic impact, for papers by Madelene Lindqvist Breakdown of academic impact, for papers by Phil Felgner Breakdown of academic impact, for papers by Lorenzo Diomede Breakdown of academic impact, for papers by Diane G. Carnathan Breakdown of academic impact, for papers by Thandavarayan Nagashunmugam Breakdown of academic impact, for papers by Danushka K. Wijesundara
Rankless by CCL
2026